Thyrocare Technologies Limited

NSEI:THYROCARE Stock Report

Market Cap: ₹52.0b

Thyrocare Technologies Management

Management criteria checks 2/4

Thyrocare Technologies' CEO is Rahul Guha, appointed in May 2022, has a tenure of 2.5 years. total yearly compensation is ₹35.00M, comprised of 40% salary and 60% bonuses, including company stock and options. directly owns 0.1% of the company’s shares, worth ₹52.72M. The average tenure of the management team and the board of directors is 1.9 years and 2.8 years respectively.

Key information

Rahul Guha

Chief executive officer

₹35.0m

Total compensation

CEO salary percentage40.0%
CEO tenure2.5yrs
CEO ownership0.1%
Management average tenure1.9yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Oct 31
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Aug 01
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 26
Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Jun 12
A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Feb 29
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 04
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Dec 08
Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 08
Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Mar 23
Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Mar 02
Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Feb 01
Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

Jan 12
Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Dec 24
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Dec 17
Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 30
Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Nov 02
Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

Nov 01
Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

CEO Compensation Analysis

How has Rahul Guha's remuneration changed compared to Thyrocare Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹840m

Jun 30 2024n/an/a

₹776m

Mar 31 2024₹35m₹14m

₹708m

Dec 31 2023n/an/a

₹655m

Sep 30 2023n/an/a

₹648m

Jun 30 2023n/an/a

₹599m

Mar 31 2023₹32mn/a

₹645m

Compensation vs Market: Rahul's total compensation ($USD414.68K) is about average for companies of similar size in the Indian market ($USD359.99K).

Compensation vs Earnings: Rahul's compensation has been consistent with company performance over the past year.

CEO

Rahul Guha (46 yo)

2.5yrs

Tenure

₹35,000,004

Compensation

Mr. Rahul Franklin Guha serves as President of Operations at API Holdings Limited since 2024. He is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 20...

Leadership Team

NamePositionTenureCompensationOwnership
Rahul Guha
MD, CEO & Chairman2.5yrs₹35.00m0.10%
₹ 52.7m
Alok Jagnani
Chief Financial Officer1.3yrs₹5.55mno data
K. KallathiKumar
Chief Operating Officerno data₹9.32m0.0030%
₹ 1.6m
Ramjee Dorai
Company Secretary & Compliance Officer10.2yrs₹3.64m0.040%
₹ 20.8m
Pratik Hire
Head of Strategy & Investor Relationsno datano datano data
Nitin Chugh
Chief Commercial Officerless than a yearno datano data
Aditya Shinde
Vice Presidentno data₹5.33m0.0020%
₹ 1.0m
Kapil Gupta
Strategy Managerno datano datano data

1.9yrs

Average Tenure

46yo

Average Age

Experienced Management: THYROCARE's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Rahul Guha
MD, CEO & Chairman2.5yrs₹35.00m0.10%
₹ 52.7m
Indumati Gopinathan
Non-Executive Independent Director7.3yrs₹240.00kno data
Dharmil Sheth
Non-Executive & Non-Independent Director3.2yrsno datano data
Hardik Dedhia
Non Executive Director3.2yrsno datano data
Dhaval Shah
Non Executive Director3.1yrsno datano data
Prapti Gilada
Independent Director1.3yrs₹220.00kno data
Harshil Vora
Non-Executive Independent Director1.3yrs₹40.00kno data
Anandh Sundar
Independent Directorno datano datano data
Nishant Shah
Independent Directorless than a yearno datano data

2.8yrs

Average Tenure

36yo

Average Age

Experienced Board: THYROCARE's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.